Search Results

There are 11922 results for: content related to: A pathophysiological interpretation of unresponsiveness to spironolactone in a stepped-care approach to the diuretic treatment of ascites in nonazotemic cirrhotic patients

  1. HYPERKALEMIC CHANGES DURING SPIRONOLACTONE THERAPY FOR CIRRHOSIS AND ASCITES, WITH SPECIAL REFERENCE TO HYPERKALEMIC INTERMITTENT PARALYSIS

    Journal of the American Geriatrics Society

    Volume 16, Issue 8, August 1968, Pages: 874–886, János P. Radó, Judit Marosi, László Szende and József Takó

    Version of Record online : 27 APR 2015, DOI: 10.1111/j.1532-5415.1968.tb02682.x

  2. Spironolactone for hypertension

    Intervention Review

    The Cochrane Library

    Josh Batterink, Sarah N Stabler, Aaron M Tejani and Curt T Fowkes

    Published Online : 4 AUG 2010, DOI: 10.1002/14651858.CD008169.pub2

  3. The mineralocorticoid receptor antagonist spironolactone enhances morphine antinociception

    European Journal of Pain

    Volume 18, Issue 3, March 2014, Pages: 386–395, T.O. Lilius, V. Jokinen, M.S. Neuvonen, A.J. Väänänen, M. Niemi, P.V. Rauhala and E.A. Kalso

    Version of Record online : 30 JUL 2013, DOI: 10.1002/j.1532-2149.2013.00371.x

  4. Spironolactone versus placebo or in combination with steroids for hirsutism and/or acne

    Intervention Review

    The Cochrane Library

    Julie Brown, Cindy Farquhar, Olivia Lee, Robyn Toomath and Ruth G Jepson

    Published Online : 15 APR 2009, DOI: 10.1002/14651858.CD000194.pub2

  5. You have free access to this content
    Interventions for hirsutism (excluding laser and photoepilation therapy alone)

    Intervention Review

    The Cochrane Library

    Esther J van Zuuren, Zbys Fedorowicz, Ben Carter and Nikolaos Pandis

    Published Online : 28 APR 2015, DOI: 10.1002/14651858.CD010334.pub2

  6. Amiloride, spironolactone, and potassium chloride in thiazide-treated hypertensive patents

    Clinical Pharmacology & Therapeutics

    Volume 27, Issue 4, April 1980, Pages: 533–543, L E Ramsay, J Hettiarachchi, R Fraser and J J Morton

    Version of Record online : 16 APR 1980, DOI: 10.1038/clpt.1980.75

  7. You have free access to this content
    Aldosterone antagonists for preventing the progression of chronic kidney disease

    Intervention Review

    The Cochrane Library

    Davide Bolignano, Suetonia C Palmer, Sankar D Navaneethan and Giovanni FM Strippoli

    Published Online : 29 APR 2014, DOI: 10.1002/14651858.CD007004.pub3

  8. Management of resistant hypertension: Aldosterone antagonists or intensification of diuretic therapy?

    Nephrology

    Volume 20, Issue 8, August 2015, Pages: 567–571, Ursula Verdalles, Soledad García de Vinuesa, Marian Goicoechea, Nicolas Macías, Alba Santos, Ana Perez de Jose, Eduardo Verde, Claudia Yuste and Jose Luño

    Version of Record online : 21 JUL 2015, DOI: 10.1111/nep.12475

  9. You have full text access to this Open Access content
    Myocardial changes after spironolactone in spontaneous hypertensive rats. A laser scanning confocal microscopy study

    Journal of Cellular and Molecular Medicine

    Volume 6, Issue 1, January 2002, Pages: 49–57, Leila Maria Meirelles Pereira and C.A. Mandarim-de-Lacerda

    Version of Record online : 1 MAY 2007, DOI: 10.1111/j.1582-4934.2002.tb00310.x

  10. You have free access to this content
    Relative potency of spironolactone, triamterene and potassium chloride in thiazide-induced hypokalaemia.

    British Journal of Clinical Pharmacology

    Volume 14, Issue 2, August 1982, Pages: 257–263, PR Jackson, LE Ramsay and V Wakefield

    Version of Record online : 26 JUL 2012, DOI: 10.1111/j.1365-2125.1982.tb01970.x

  11. Diuretics acting on the distal renal tubule for preterm infants with (or developing) chronic lung disease

    Intervention Review

    The Cochrane Library

    Audra Stewart, Luc P Brion and Iris Ambrosio-Perez

    Published Online : 7 SEP 2011, DOI: 10.1002/14651858.CD001817.pub2

  12. You have free access to this content
    Spironolactone Use in Heart Failure Patients With End-Stage Renal Disease on Hemodialysis: Is It Safe?

    Clinical Cardiology

    Volume 33, Issue 10, October 2010, Pages: 604–608, Doson Chua, Anita Lo and Chris Lo

    Version of Record online : 19 OCT 2010, DOI: 10.1002/clc.20838

  13. Comparison of electrospun and extruded soluplus®-based solid dosage forms of improved dissolution

    Journal of Pharmaceutical Sciences

    Volume 101, Issue 1, January 2012, Pages: 322–332, Zsombor K. Nagy, Attila Balogh, Balázs Vajna, Attila Farkas, Gergő Patyi, Áron Kramarics and György Marosi

    Version of Record online : 23 AUG 2011, DOI: 10.1002/jps.22731

  14. Medical Treatment of Ascites in Cirrhosis

    Ascites and Renal Dysfunction in Liver Disease: Pathogenesis, Diagnosis, and Treatment, Second Edition

    Paolo Angeli, Angelo Gatta, Pages: 227–240, 2007

    Published Online : 25 OCT 2007, DOI: 10.1002/9780470987476.ch18

  15. You have free access to this content
    Protective effects of spironolactone against anthracycline-induced cardiomyopathy

    European Journal of Heart Failure

    Volume 17, Issue 1, January 2015, Pages: 81–89, Mahmut Akpek, Ibrahim Ozdogru, Omer Sahin, Mevlude Inanc, Ali Dogan, Cevat Yazici, Veli Berk, Halit Karaca, Nihat Kalay, Abdurrahman Oguzhan and Ali Ergin

    Version of Record online : 20 NOV 2014, DOI: 10.1002/ejhf.196

  16. Spironolactone diminishes urinary albumin excretion in patients with type 1 diabetes and microalbuminuria: a randomized placebo-controlled crossover study

    Diabetic Medicine

    Volume 29, Issue 8, August 2012, Pages: e184–e190, S. E. Nielsen, F. Persson, E. Frandsen, T. Sugaya, G. Hess, D. Zdunek, K. J. Shjoedt, H-H. Parving and P. Rossing

    Version of Record online : 15 JUL 2012, DOI: 10.1111/j.1464-5491.2012.03585.x

  17. Hepatorenal syndrome and ascites - questions and answers

    Liver

    Volume 19, Issue s1, December 1999, Pages: 15–74, M. Bernardi, L. Blendis, A. K. Burroughs, G. Laffi, J. Rodes and P. Gentilini

    Version of Record online : 2 MAR 2007, DOI: 10.1111/j.1478-3231.1999.tb00092.x

  18. Pathogenesis, Diagnosis and Treatment of Ascites in Cirrhosis

    Textbook of Hepatology: From Basic Science to Clinical Practice, Third Edition

    Vicente Arroyo, Carlos Terra, Luis Ruiz-del-Arbol, Pages: 666–710, 2008

    Published Online : 15 APR 2008, DOI: 10.1002/9780470691861.ch7e

  19. Metolazone and spironolactone in cirrhosis and the nephrotic syndrome

    Clinical Pharmacology & Therapeutics

    Volume 21, Issue 2, February 1977, Pages: 234–243, Gordon R. Lang, Christof Westenfelder, Luiz Nascimento, Virendra B. Dhupelia, Jose A. L. Arruda and Robert E. Kane

    Version of Record online : 4 JAN 2016, DOI: 10.1002/cpt1977212234

  20. You have free access to this content
    Efficacy and tolerability of adding an angiotensin receptor blocker in patients with heart failure already receiving an angiotensin-converting inhibitor plus aldosterone antagonist, with or without a beta blocker. Findings from the Candesartan in Heart failure: Assessment of Reduction in Mortality and morbidity (CHARM)-Added trial

    European Journal of Heart Failure

    Volume 10, Issue 2, February 2008, Pages: 157–163, R.A.P. Weir, John J.V. McMurray, Margareta Puu, Scott D. Solomon, Bertil Olofsson, Christopher B. Granger, Salim Yusuf, Eric L. Michelson, Karl Swedberg, Marc A. Pfeffer and CHARM Investigators

    Version of Record online : 13 JAN 2014, DOI: 10.1016/j.ejheart.2007.12.006